Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
How Insider Sale and VIR-5500 Milestone at Vir Biotechnology (VIR) Have Changed Its Investment Story
Vir Biotechnology (NASDAQ:VIR) Director Vicki Sato Sells 22,000 Shares
Vir Biotechnology (VIR) Projected to Post Quarterly Earnings on Wednesday - Zolmax
Vir Biotechnology (VIR) Expected to Announce Quarterly Earnings on Wednesday
Assessing Vir Biotechnology (VIR) Valuation After Recent Share Price Momentum
Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?
Vir Biotechnology (VIR) Posts 80.98% Year-To-Date Growth
10 Best Small-Cap Biotech Stocks According to Hedge Funds
Vir Biotechnology (VIR) Is Up 19.1% After Astellas Cancer Pact Closes With $315M Inflows
Can Vir Biotechnology (VIR)'s Masked T-Cell Technology Crack the Hardest-to-Treat Prostate Cancer?
Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year High - Here's Why - Stock Observer
Is Vir Biotechnology (VIR) One of the Best Low Priced Biotech Stocks to Invest In?
Vir Biotechnology (VIR) Valuation After Astellas Partnership And New VIR 5500 Trial Milestone
Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer | Morningstar
Phase 1 trial designed to assess the safety, pharmacokinetic
Brokerages Set Vir Biotechnology, Inc. (NASDAQ:VIR) PT at $20.44
Should Vir's CMO Exit and Astellas Funding Boost Reshape How Investors View Its R&D Strategy (VIR)?
Vir Biotechnology (VIR) Leading with Its BiTEs Therapy
Aberdeen Group plc Sells 135,688 Shares of Vir Biotechnology, Inc. $VIR
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Brokerages
Vir Biotechnology (NASDAQ:VIR) CEO Backer Marianne De Sells 72,559 Shares
Latest news
Show moreRussia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict
Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions
Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis
